SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011859
Filing Date
2021-05-17
Accepted
2021-05-17 16:16:12
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 435825
2 ex31.htm EX-31 22810
3 ex32.htm EX-32 5724
  Complete submission text file 0001493152-21-011859.txt   3266273

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE age-20210331.xml EX-101.INS 478273
5 XBRL SCHEMA FILE age-20210331.xsd EX-101.SCH 38186
6 XBRL CALCULATION FILE age-20210331_cal.xml EX-101.CAL 62542
7 XBRL DEFINITION FILE age-20210331_def.xml EX-101.DEF 190835
8 XBRL LABEL FILE age-20210331_lab.xml EX-101.LAB 287816
9 XBRL PRESENTATION FILE age-20210331_pre.xml EX-101.PRE 253829
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 21930859
SIC: 2834 Pharmaceutical Preparations